Respiratory Syncytial Virus (RSV) Induces Innate Immunity through Toll-Like Receptors and Acquired Immunity via the RSV G Protein: A Dissertation

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease

  2010influential reference
• Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice.

  2009influential reference
• An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice

  2009cited by this paper
• Human Respiratory Syncytial Virus Nonstructural Protein NS2 Antagonizes the Activation of Beta Interferon Transcription by Interacting with RIG-I

  2009cited by this paper
• Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.

  2009cited by this paper
• Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.

  2008cited by this paper
• Nonstructural Proteins 1 and 2 of Respiratory Syncytial Virus Suppress Maturation of Human Dendritic Cells

  2008cited by this paper
• The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes

  2008cited by this paper
• Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15)

  2008cited by this paper
• Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2

  2008cited by this paper
• Purification of human respiratory syncytial virus by ultracentrifugation in iodixanol density gradient

  2008cited by this paper
• Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.

  2008cited by this paper
• Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance.

  2008cited by this paper
• Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat.

  2008cited by this paper
• Function of the Respiratory Syncytial Virus Small Hydrophobic Protein

  2007influential reference
• Uptake of Human Papillomavirus Virus-Like Particles by Dendritic Cells Is Mediated by Fcγ Receptors and Contributes to Acquisition of T Cell Immunity1

  2007cited by this paper
• Toll-like receptors and innate immunity in B-cell activation and antibody responses.

  2007cited by this paper
• Immunopathology of RSV infection: prospects for developing vaccines without this complication

  2007influential reference
• MyD88-Mediated Instructive Signals in Dendritic Cells Regulate Pulmonary Immune Responses during Respiratory Virus Infection1

  2007cited by this paper
• Severe Human Lower Respiratory Tract Illness Caused by Respiratory Syncytial Virus and Influenza Virus Is Characterized by the Absence of Pulmonary Cytotoxic Lymphocyte Responses

  2007cited by this paper
• Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection.

  2007cited by this paper
• TLR4 Polymorphisms Mediate Impaired Responses to Respiratory Syncytial Virus and Lipopolysaccharide1

  2007cited by this paper
• Venezuelan Equine Encephalitis Virus Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats

  2007cited by this paper
• C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.

  2007cited by this paper
• Toll‐like receptors 1 and 6 are involved in TLR2‐mediated macrophage activation by hepatitis C virus core and NS3 proteins

  2007cited by this paper
• Tumor necrosis factor-alpha (TNF-alpha) regulates Toll-like receptor 2 (TLR2) expression in microglia.

  2007cited by this paper
• Tumor necrosis factor‐alpha (TNF‐α) regulates Toll‐like receptor 2 (TLR2) expression in microglia

  2007cited by this paper
• Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta.

  2007cited by this paper
• Association of TLR4 Polymorphisms with Symptomatic Respiratory Syncytial Virus Infection in High-Risk Infants and Young Children1

  2007cited by this paper
• Respiratory syncytial virus and metapneumovirus

  2007cited by this paper
• Host Transcription Profiles upon Primary Respiratory Syncytial Virus Infection

  2007cited by this paper
• Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses

  2006cited by this paper
• Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes.

  2006cited by this paper
• Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus

  2006cited by this paper
• Differential Chemokine Expression following Respiratory Virus Infection Reflects Th1- or Th2-Biased Immunopathology

  2006cited by this paper
• Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle.

  2006cited by this paper
• Innate immune recognition of viral infection

  2006cited by this paper
• Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms.

  2006cited by this paper
• Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection

  2006cited by this paper
• Suppression of pattern-recognition receptor TLR4 sensing does not alter lung responses to pneumovirus infection.

  2006cited by this paper
• The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease.

  2006influential reference
• Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells

  2006cited by this paper
• Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles

  2006influential reference
• The Cysteine-Rich Region and Secreted Form of the Attachment G Glycoprotein of Respiratory Syncytial Virus Enhance the Cytotoxic T-Lymphocyte Response despite Lacking Major Histocompatibility Complex Class I-Restricted Epitopes

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes

  2006cited by this paper
• Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a review

  2006cited by this paper
• Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses

  2006cited by this paper
• Innate sensing of self and non-self RNAs by Toll-like receptors.

  2006cited by this paper
• Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment

  2006cited by this paper
• Integrity of Membrane Lipid Rafts Is Necessary for the Ordered Assembly and Release of Infectious Newcastle Disease Virus Particles

  2006cited by this paper
• Protection of mice against Human respiratory syncytial virus by wild-type and aglycosyl mouse-human chimaeric IgG antibodies to subgroup-conserved epitopes on the G glycoprotein.

  2006cited by this paper
• Inhibition of Receptor Binding Stabilizes Newcastle Disease Virus HN and F Protein-Containing Complexes

  2006cited by this paper
• Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

  2006cited by this paper
• Toll-like receptors.

  2005cited by this paper
• Pathogenesis of respiratory syncytial virus infection in the murine model.

  2005cited by this paper
• The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.

  2005cited by this paper
• Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.

  2005cited by this paper
• Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

  2005cited by this paper
• Effects of Nonstructural Proteins NS1 and NS2 of Human Respiratory Syncytial Virus on Interferon Regulatory Factor 3, NF-κB, and Proinflammatory Cytokines

  2005cited by this paper
• Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation

  2005cited by this paper
• Dendritic Cells: Sentinels of Immunity and Tolerance

  2005cited by this paper
• Control of B-cell responses by Toll-like receptors

  2005cited by this paper
• Respiratory Syncytial Virus Nonstructural Proteins NS1 and NS2 Mediate Inhibition of Stat2 Expression and Alpha/Beta Interferon Responsiveness

  2005influential reference
• MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection

  2005cited by this paper
• Co-immunization of BALB/c mice with recombinant immunogens containing G protein fragment and chimeric CTL epitope of respiratory syncytial virus induces enhanced cellular immunity and high level of antibody response.

  2005cited by this paper
• Respiratory syncytial virus and neutrophil activation

  2005cited by this paper
• A function for interleukin 2 in Foxp3-expressing regulatory T cells

  2005cited by this paper
• Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.

  2005cited by this paper
• Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus

  2005cited by this paper
• The role of Toll‐like receptor 4 versus interleukin‐12 in immunity to respiratory syncytial virus

  2004cited by this paper
• Respiratory Syncytial Virus (RSV) G Glycoprotein Is Not Necessary for Vaccine-Enhanced Disease Induced by Immunization with Formalin-Inactivated RSV

  2004cited by this paper
• Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.

  2004cited by this paper
• Rapid Response of Marginal Zone B Cells to Viral Particles

  2004cited by this paper
• Tolerance, not immunity, crucially depends on IL-2

  2004influential reference
• Suppression of the Induction of Alpha, Beta, and Gamma Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

  2004cited by this paper
• Suppression of the Induction of Alpha, Beta, and Lambda Interferons by the NS1 and NS2 Proteins of Human Respiratory Syncytial Virus in Human Epithelial Cells and Macrophages

  2004cited by this paper
• A Mutant Stat5b with Weaker DNA Binding Affinity Defines a Key Defective Pathway in Nonobese Diabetic Mice*

  2004cited by this paper
• National disease burden of respiratory viruses detected in children by polymerase chain reaction

  2004cited by this paper
• Respiratory syncytial virus: The virus, the disease and the immune response

  2004cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper
• Mortality associated with influenza and respiratory syncytial virus in the United States.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance1

  2003cited by this paper
• Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

  2003cited by this paper
• TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase.

  2003cited by this paper
• Respiratory syncytial virus infection activates STAT signaling in human epithelial cells.

  2003cited by this paper
• Virokinin, a Bioactive Peptide of the Tachykinin Family, Is Released from the Fusion Protein of Bovine Respiratory Syncytial Virus*

  2003cited by this paper
• Do lipid rafts mediate virus assembly and pseudotyping?

  2003cited by this paper
• In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway 1

  2003influential reference
• Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus

  2003cited by this paper
• Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2

  2003cited by this paper
• Evidence for Mixed Membrane Topology of the Newcastle Disease Virus Fusion Protein

  2003cited by this paper
• Adjuvants recognized by toll-like receptors inhibit the induction of polarized type 2 T cell responses by natural attachment (G) protein of respiratory syncytial virus.

  2003cited by this paper
• Virus-like particles as immunogens.

  2003cited by this paper
• Palivizumab prophylaxis of respiratory syncytial virus disease in 2000–2001: Results from the palivizumab outcomes registry

  2003cited by this paper
• Genetic susceptibility to respiratory syncytial virus infection in inbred mice

  2002influential reference
• Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious Cytopathology

  2002cited by this paper
• Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

  2002cited by this paper
• Neutrophil survival is prolonged in the airways of healthy infants and infants with RSV bronchiolitis

  2002cited by this paper

• HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-alpha and IL-10

  2017cites this paper
• Mumps virus-induced innate immune responses in mouse Sertoli and Leydig cells

  2016cites this paper